| Name | Title | Contact Details |
|---|
1800CHIRO is a La Jolla, CA-based company in the Business Services sector.
A leading AI & Cloud Computing company based in Abu Dhabi, committed to inventing a better everyday through the power of people and technology. We see technology as the next frontier of humanity and solve complex challenges across multiple industries with a holistic and far-reaching systemic view. We join forces with the best of the best to move the world forward, partnering with nations, corporations and individuals. From molecular medicine to space travel and everything in between, together, we are inventing a better everyday. Visit www.g42.ai for more information.
High on the Hog Catering is a Bridgeport, CT-based company in the Business Services sector.
At Apollo Intelligence Corporation (Apollo) we are committed to delivering best-in-class, technology-driven data and insights solutions to our customers in the global Life Sciences and Healthcare industries.
Oculis (Nasdaq: OCS) is a global biopharmaceutical company purposefully driven to save sight and improve eye care. Oculis highly differentiated clinical-stage pipeline comprises multiple innovative product candidates in development for eye diseases of high unmet need. It includes OCS-01 eye drops, a topical candidate in Phase 3 development for diabetic macular edema (DME) and inflammation and pain following ocular surgery; OCS-02 eye drops, a topical biologic candidate in Phase 2 development for dry eye disease (DED) and uveitis; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophthalmic disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The first in-patient, proof-of-concept trial with OCS-05 is currently ongoing in France. Headquartered in Switzerland and with operations in the US, Europe, and China, Oculis goal is to deliver life-changing eye treatments to patients worldwide. The company is led by an experienced management team with a successful track record in the pharmaceutical industry, supported by leading international healthcare investors.